For the better part of five years, a coalition of environmental groups and tort lawyers (aided by the mainstream press) has relentlessly asserted that the weedkiller glyphosate poses a serious cancer risk. A team of respected epidemiologists poured gasoline on this already raging fire in 2018, when they published a meta-analysis (which Ill refer to as the Zhang paper after the first author) that found a significant association between glyphosate exposure and the risk of non-Hodgkins lymphoma (NHL).
In part one of this series, I detailed how the authors of what appeared to be an important paper made some highly questionable decisions in order to reach their conclusion, namely selecting certain data points and excluding others from the studies they considered. Despite the serious defects that I and a few other scientists pointed out soon after the paper appeared online, the papers conclusion that relatively heavy exposure to glyphosate was associated with a 41 percent increased risk of NHL ensured that it would get widespread publicity.
But there were still other indications of bias in the paper that provide insight into the authors thinking. In this follow-up piece, I want to examine some of the other instances of bias, then address three crucial questions. How could this paper, flawed as it is, have passed peer review and largely escaped serious criticism in the two years following publication? What does the Zhang paper reveal about the authors mindset, and about standards of scholarship in the field of environmental epidemiology? And, finally, what are the implications for efforts to produce reliable science that can guide policy makers and consumers?
Well before I got to the heart of the Zhang paper, I picked up signals that put my critical antennae on guard. On page three, the authors stated, GBHs [glyphosate-based herbicides] have recently undergone a number of regional, national, and international evaluations for carcinogenicity in humans [20-23], resulting in considerable controversy regarding glyphosate and GBHs overall carcinogenic potential.
In order to support their claim of considerable controversy, the authors provided two references to agencies that found that glyphosate is not a health concern (US Environmental Protection Agency, EPA; Joint FAO/WHO Meeting on Pesticide Residues, JMPR) and two that found it to be a probable carcinogen (The International Agency for Research on Cancer, IARC; and Californias Office of Environmental Health Hazard Assessment, OEHHA), thus implying that opinion is evenly divided and balanced.
In fact, roughly a dozen national and international agencies have found glyphosate to be safe and non-carcinogenic (EPA, Health Canada, the European Food Safety Authority, the European Chemicals Authority, the UNs Food and Agriculture Organization, and the health agencies of France, Germany, Australia, New Zealand, Japan, and Brazil). The fact is that IARC is the only major agency that has found glyphosate to be problematic, and its analysis has been deemed defective by many independent experts. As for OEHHA, it mechanically follows IARC in its designation of carcinogens under Californias Proposition 65, a byzantine law approved by voters in 1986 that has led the Golden State to list garlic bread and, for a time, coffee as possible carcinogens.
Whatever controversy over glyphosate there is, then, is the product of political and legal considerations, not evidence that the weedkiller causes cancer. However, the assertion that there is considerable controversy is important to the Zhang authors because, in their telling, it is what motivated their meta-analysis, as the following sentence makes clear: Hence, addressing the question of whether or not GBHs are associated with NHL has become even more critical (emphasis mine).
Throughout the paper, there are other similarly one-sided characterizations of the evidence on specific topics.
First, in their introduction, the authors emphasized the amount of glyphosate used in the past decade and noted that it has been detected in various foods and baby formula, concluding that glyphosate may be considered ubiquitous in the environment. However, they omitted that glyphosate has relatively low acute and chronic toxicity compared to other pesticides and that the levels detected in foods are well below the level at which any adverse effects would be expected.
They observed that use of glyphosate increased roughly 16-fold between 1992 and 2009, but they failed to note that the incidence of NHL has remained unchanged over the past thirty years.
Second, they articulated criticisms of the Agricultural Health Study (AHS) at length based on secondary considerations, but failed to note its strengths. The AHS is, in fact, the best epidemiological investigation of glyphosates cancer-causing potential, and it poses a significant challenge to Zhangs conclusion. It is striking that the authors failed to note the much more serious problems with the case-control studies they inappropriately combined with the AHS (Read part one for a full analysis of this issue).
Third, to supplement the results of the meta-analysis of human studies, Zhang et al. summarized the results of studies of lymphomas in mice following the administration of glyphosate, which they interpreted as providing additional evidence of the carcinogenicity of glyphosate. However, the evidence appears mixed and, where increasing trends were seen in the tumor yield with increasing doses of glyphosate, they were modest. Researchers have evaluated glyphosate rodent studies for all tumor sites and found more instances of tumor decreases with increasing glyphosate exposure levels than tumor increases.
Finally, the authors pointed to a number of biological mechanisms that may play a role in the development NHL in humans and of lymphoma in animals. While such mechanisms are worthy of study, it is generally recognized that the results of laboratory studies are less directly relevant to risk assessment than epidemiologic studies and, secondarily, animal experiments.
Thus, there is a pattern throughout the Zhang paper of what I call motivated reasoning. Rather than evaluating the evidence on its merits, the authors constructed a narrative designed to support their a priori hypothesis. In other words, their critical faculties served to imprison them in their motivated thinking, always a danger in science thatphysicist Richard Feynman addressed in his 1974 commencement address at Caltech titled Cargo Cult Science. Feynman emphasized that when you formulate a hypothesis, you must list all the observations and facts that support it, but you must also list all of the observations and facts that do not agree with it. This is the only way not to fool yourselfand, Feynman added, you are the easiest person to fool.
Given the Zhang papers unjustified assumptions and methodological flaws, how did it survive peer review? Peer review is a lottery, by which I mean the quality of the review depends very much on the individuals who perform the review, as well as the editor who oversees the review. Some reviewers are tough minded and the study author senses they miss nothing in evaluating a paper.
At the other extreme, reviewers who are less alert or less methodologically astute may feel that the authors have made a convincing case. I would argue that Zhang et al. wrote their paper with an emphasis on justifying their choices and judgments rhetorically, if not scientifically. One almost feels snowed by their arguments. And their style of argumentation appears to have been very effective. What is clear is that neither the editors nor the reviewers noticed the pattern of motivated reasoning, selective attention to facts, and unsupported assumptions that I have described.
The fact that the Zhang paper was published in Mutation Research, a publication with a broad focus on genetic toxicology, rather than in an epidemiology journal may have increased the likelihood of an inadequate review of a paper reporting on a meta-analysis of observational epidemiology studies.
The authors response to substantive criticism has been revealing. Rather than acknowledging criticism and presenting valid arguments to support their position or modifying it, they doubled down on their hypothesis and tried to divert attention from the key issues, while asserting the transparency and quality of their work. In addition, they implied that their critics must have some conflict of interest.
I will give just one example among many. In her February 2020 Forbes piece, responding after a full year to my critique published in February 2019, Lianne Sheppard, the Zhang papers senior author, wrote that cherry-picking of data to achieve particular results is never acceptable scientific practice, and in the case of our meta-analysis, this claim is not true. But, based on her a priori hypothesis, she defended her selection of the one relative risk out of five from the AHS (relative risk 1.12) that ensured a statistically significant result.
This was not the main analysis presented by the AHS researchers in their paper that was the unlagged relative risk of 0.87. And, as I made clear in part one, there are two glaring facts that should have motivated Sheppard to reconsider her choice. First, the AHS, by far the largest and most careful study, showed no support for her a priori hypothesis that the highest exposure group would show the strongest association and demonstrated this point in all five analyses! Second, as the Zhang authors themselves acknowledged, the latency period for NHL to develop is uncertain, and could be as short as two years, although their conclusion is based on the assumption that it is 20 years. Recognition of both these facts should have made the authors reconsider the justification for their analysis.
After this evasion of the science, Sheppard went on to raise further diversions, arguing that publications in the popular media are not appropriate for the serious business of evaluating risks scientifically. Only the sacred precincts of academic journalswhere my colleagues and I have recently published a thorough critique of the Zhang paper are suitable venues for such discussion. Sheppard seems unaware of the flourishing, real-time discussions of critical issues in science and medicine by the likes of Eric Topol, Peter Hotez, Vinay Prasad, and many others on Twittter. True scientists are happy to engage with an interested audience, whatever the forum.
I have devoted time to examining this paper because I believe it is symptomatic of a state of mind that is prevalent in environmental and lifestyle epidemiology. This area is challenging due to the difficulty of measuring human exposure to low-level environmental agentsoften measured at a single point in timeand gauging their long-term health effects against the background of exposures that are often orders of magnitude stronger (smoking, alcohol consumption, diet, body mass index, postmenopausal hormones, etc). Nevertheless, numerous papers continue to be published examining the association of self-reported exposures to trace levels of chemicals in urine or blood with risk of some chronic disease.
There are those working in this area who appear to feel that, in spite of the limitations of the studiesor, perhaps, because of these limitationsone has to take seriously results that are suggestive of an association. In a sense, because of the difficulty of documenting low-level exposures, scientists may feel that they have to give them the benefit of the doubt. Given the limitations of the data, the findings of such studies need to be interpreted with an allowance for the fact that the studies cant tell us what we want to know.
The science policy scholar Daniel Sarewitz has used the term trans-science to refer to the study of complex questions that cant be answered by present-day science. In the absence of definitive data, what seems to be most important to these people is their interest in the question regarding the effects of a particular chemical agent. This is how results from weak studies that appear to point to a risk can be seized on, and this is what appears to have happened in the Zhang paper. What is lacking in high-quality evidence is compensated for by ideological and moral zeal.
Researchers are keenly aware that the media, the public, and even journal editors and reviewers are sensitive to findings that appear to implicate a common exposure in chronic disease. Where strong data are lacking but the issue is one that will resonate with the public and the media, scientists know that their message will get picked up and get traction. Weve seen many examples of this in research on electromagnetic fields, endocrine disrupting chemicals and BPA, DDT and other pesticides, e-cigarettes, and many other issues.
A number of agencies and institutions have been associated with this type of motivated sciencethe International Agency for Research on Cancer (IARC) regarding glyphosate, cell phones, and other exposures; the National Institute for Environmental Health Sciences (NIEHS) regarding BPA; and the Endocrine Society regarding endocrine-disrupting chemicals generally.
In contrast to the kind of science exemplified by the Zhang paper, there are examples of sober and careful work by scientists who are trying to advance knowledge in their field by building on firm results and framing new hypotheses. This work, however, is unlikely to attract media attention.
A recent paper by Moubadder et al. has reviewed environmental exposures in relation to NHL. With regard to environmental exposures, they noted that several infectious agents have been causally linked to NHL. However, with regard to chemical exposures, they concluded that numerous studies have attempted to link NHL risk to chemical exposures, but in spite of many reported associations, causality has not been established.
Commenting on the Zhang meta-analysis, they had this to say:
A recent meta-analysis that included the 2018 Agricultural Health Study (AHS), a cohort of pesticide applicators that have been followed prospectively, and five casecontrol studies found the relative risk of NHL to increase by 41% among those highly exposed to glyphosate-based herbicides [meta-risk ratio (RR) = 1.41; 95% CI, 1.131.75; ref. 20]. However, studies on the AHS population alone, which includes 515 incident NHL cases, have consistently observed no association between reported glyphosate exposure and NHL risk, regardless of the latency period (i.e., 5-, 10-, 15-, and 20-year lag times; refs. 21, 22).
Taking a broad view of the role of environmental exposures in the etiology of NHL, Moubadder considered glyphosate specifically, but still came to the conclusion that causality has not been shown for any chemical.
In contemplating the contrast between the Moubadder paper and the Zhang paper, I was reminded of interviewing the reproductive expert Richard Sharpe about the huge amount of fruitless research that had been devoted to BPA as a cause of adverse reproductive events. In the early 1990s Sharpe had been one of the originators of the so-called environmental estrogen hypothesis and had seen it grow into a huge academic bandwagon, which he dissociated himself from. Sharpe shifted his attention to studying the effects of pharmaceuticals taken by pregnant women on the fetus and the developing child, as well as other exposures. The shift away from studying trace exposures to BPA to more significant exposures has already led to evidence of real effects.
Explaining why he went his own way, he said, I was lucky that the question that drove me was what causes these disorders? not how do EDCs [endocrine disrupting chemicals] cause these disorders? Such a simple difference, but it takes your thought processes in a very different direction.
Geoffrey Kabat is a cancer epidemiologist and the author ofGetting Risk Right: Understanding the Science of Elusive Health Risks. Find Geoffrey on Twitter@GeoKabat
- The Ethical, Legal, and Social Issues Impacted by Modern ... - Hindawi - November 25th, 2022
- BSGM - The British Society for Genetic Medicine - November 25th, 2022
- Feasibility and ethics of using data from the Scottish newborn blood spot archive for research | Communications Medicine - Nature.com - October 7th, 2022
- Closing your health care practice: What you need to know - Medical Economics - October 7th, 2022
- Is the doctor's office heading for extinction? - Medical Economics - October 7th, 2022
- Abortion Access in the U.S.: What to Know on a State-By-State Level - Healthline - October 7th, 2022
- Students can create their own path with new ASU Online biology degree - ASU News Now - October 7th, 2022
- U.S. Releases an AI Bill Of Rights That Though Encouraging Won't Yet Move the Needle - JURIST - October 7th, 2022
- California Funds Research On Blocking Marijuana Monopolies And Protecting 'Legacy' Cannabis Strains - Marijuana Moment - October 7th, 2022
- Tips For Your Virtual Meetings With The FDA - Med Device Online - October 7th, 2022
- Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed ... - The Bakersfield Californian - October 7th, 2022
- MeiraGTx Announces the Upcoming Presentation of 15 Abstracts at the European Society of Gene and Cell Therapy (ESGCT) 2022 Annual Congress -... - October 7th, 2022
- Neighborhood deprivation and coronary heart disease in patients with bipolar disorder | Scientific Reports - Nature.com - October 7th, 2022
- Have Insurers Paid Too Much for Asbestos and Other Toxic Torts? - Claims Journal - August 19th, 2022
- Restrictive abortion laws are limiting the options parents have after receiving genetic test results, experts say - Yahoo Singapore News - August 19th, 2022
- Neurologists Discuss the Impact of Roe v. Wade Reversal on... : Neurology Today - LWW Journals - August 19th, 2022
- Abortion ruling prompts variety of reactions from states - ABC News - August 19th, 2022
- Is pregnancy possible after multiple failed IVF attempts? Can your frozen eggs and sperm be as healthy later? - The Indian Express - August 19th, 2022
- Meet the Expert: Focus on orthopaedics and VTE - Hospital Healthcare Europe - August 19th, 2022
- Egg Donation Process: From Application to Recovery - Healthline - July 6th, 2021
- Patent protection of mRNA vaccines and regulatory authorization - Lexology - July 6th, 2021
- EAPM: Presidency bridging conference a great success, HTA compromise agreed and data on the agenda - EU Reporter - July 6th, 2021
- Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies - PRNewswire - April 4th, 2021
- Legally blind Great Falls filmmakers share their vision in national challenge - Yahoo News - April 4th, 2021
- Pfizer Announces Vaccine Is 100% Protective Against Coronavirus In Kids As Young As 12 - Yahoo News - April 4th, 2021
- How the law will change in 2021 - Lexology - February 11th, 2021
- Writing is the best medicine - The London Economic - February 11th, 2021
- The Error of Fighting a Public Health War With Medical Weapons - WIRED - January 2nd, 2021
- Moderna, Pfizer vaccine trials were the highest of quality: vaccine expert - Yahoo Money - January 2nd, 2021
- Celebrate the new year with this New Year's Eve fireworks show in SF - Yahoo News - January 2nd, 2021
- The movie industry will strengthen again around April or May: Screenvision CEO - Yahoo Money - January 2nd, 2021
- Congress overrides Donald Trump's veto of a defense policy bill in the first such rebuke of his presidency - Yahoo News - January 2nd, 2021
- How the pandemic enabled a robot revolution - Politico - December 4th, 2020
- The mink link: How COVID-19 mutations in animals affect human health and vaccine effectiveness - The Conversation CA - November 24th, 2020
- How vaccines get made and approved in the US - The Albany Herald - November 24th, 2020
- Legalization votes bring worries of increased youth marijuana use, but evidence remains murky - AberdeenNews.com - November 24th, 2020
- Your daily 6: Third vaccine looks effective, no single 'word of the year' and Trump team called 'a national embarrassment' - Ravalli Republic - November 24th, 2020
- Cybersecurity depends on the user - Modern Diplomacy - November 20th, 2020
- It's Been Exactly One Year Since the First Case of COVID Was Found in China - Newsweek - November 20th, 2020
- Risks and benefits of an AI revolution in medicine - Harvard Gazette - November 12th, 2020
- HHS eased oversight of Covid-19 tests though it knew of problems - STAT - November 3rd, 2020
- Who won this years Nobel science prizes? - The Economist - October 8th, 2020
- Patent and Patient Rights in COVID-19: Is the Right to Exclusivity a Hamlet Question? - The Leaflet - October 8th, 2020
- FDA Oversight of Laboratory-Developed Tests Continues To Evolve - JD Supra - October 8th, 2020
- One Sperm Donor. 36 Children. A Mess of Lawsuits. - The Atlantic - September 15th, 2020
- Nebraska Medical Bill initiative blocked from entering the November ballots - Cannabis Health Insider - September 15th, 2020
- Poaching pressure mounts on jaguars, the Americas' iconic big cat - Mongabay.com - September 15th, 2020
- 'There is a sense of being robbed': Olympian Caster Semenya loses appeal on testosterone rule - The World - September 15th, 2020
- Global Microbiome Sequencing Market Growth Drivers, Demands, Business Opportunities and Demand Forecast to 2026|Clinical-Microbiomics A/S; Diversigen;... - September 5th, 2020
- Legal and Regulatory Issues in Genetic Information ... - August 31st, 2020
- The legal aspects of genetic testing - Medical Defence Union - August 31st, 2020
- Their view: Now is not the time to legalize marijuana - Wilkes Barre Times-Leader - August 31st, 2020
- Weighing up the potential benefits and harms of comprehensive full body health checks - Croakey - August 24th, 2020
- Soon, India will have its dedicated vaccine portal: ICMR - ETHealthworld.com - August 24th, 2020
- Two Families, Two Fates: When the Misdiagnosis is Child Abuse - The Marshall Project - August 22nd, 2020
- Ron Evans steals a trick from I/O, and points the way to a transformational diabetes therapy - Endpoints News - August 22nd, 2020
- Contact tracing apps may be ineffective for reducing Covid-19 spread: Study - ETHealthworld.com - August 22nd, 2020
- Global Microbiome Sequencing Market Size 2020 Review, Growth Strategy, Developing Technologies And Forecast By 2026|Charles River; CoreBiome, Inc.;... - August 19th, 2020
- Bill Jones: Working to create a culture of education - Wilkes Barre Times-Leader - August 19th, 2020
- Whats next for abortion legislation in the U.S.? - PBS NewsHour - July 10th, 2020
- No ethics when it comes to US enemies, even in the middle of a deadly pandemic - IOL - July 10th, 2020
- IML conducts the 5th National Convention on Medicine and Law - ETHealthworld.com - July 10th, 2020
- Wayne Medicine and Wayne Law professors team up to explore legal and ethical issues of wastewater monitoring for COVID-19 - The South End - June 28th, 2020
- Challenge trials aren't the answer to a speedy Covid-19 vaccine - STAT - June 28th, 2020
- Trump Suspends H-1B and Other Visas That Allow Foreigners to Work in the U.S. - The New York Times - June 24th, 2020
- Could the Montreal Neuro herald a paradigm shift in scientific research? - University Affairs - June 24th, 2020
- Next-Generation Sequencing Market: Understanding The Key Product Segments And Their Future During 2020 -2025 - 3rd Watch News - June 24th, 2020
- Meet 'Gastruloid': The First Human Embryo-like Model From Stem Cells That Could Soon Save Many Babie - Science Times - June 12th, 2020
- Could these senolytic drugs halt the spread of COVID-19? - Health Europa - June 12th, 2020
- The coronavirus vaccine frontrunners have emerged. Here's where they stand - BioPharma Dive - June 12th, 2020
- Regulating marine genetic resources in areas beyond national jurisdiction - The Daily Star - June 12th, 2020
- Vaccines have saved millions of lives, but history shows missteps can prove deadly - The Boston Globe - June 12th, 2020
- Quitting smoking might reduce severe coronavirus infection risk: Study - ETHealthworld.com - May 23rd, 2020
- Where Taiwan Can Make the Most of AI - Taiwan - Taiwan Business TOPICS - May 23rd, 2020
- WHO and IOC team up to improve health through sport - ETHealthworld.com - May 18th, 2020
- The Cell Therapy Industry to 2028: Global Market & Technology Analysis, Company Profiles of 309 Players (170 Involved in Stem Cells) -... - May 15th, 2020
- Medical School: Who gets in and why - Stuff.co.nz - May 15th, 2020
- Wilson Ighodalo: Addressing Substance Abuse as a Public Health Problem - THISDAY Newspapers - May 15th, 2020
- The Falsehoods of the 'Plandemic' Video - FactCheck.org - May 14th, 2020
- Robert Youngjohns, Chairman of the Board, ABBYY - Interview Series - Unite.AI - May 14th, 2020